To validate the association between high TACSTD2 expression and elevated levels of H3K4me3 at the TACSTD2 promoter in colorectal cancer patients, first the expression values of TACSTD2 in 6 CRC patients was evaluated for which both, ChIP and RNA-Seq data, were available (GSE15661324). This evidence concerns the gene TACSTD2 and colorectal carcinoma.